Navigation Links
New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma

> 3:30 p.m. CT

-- Safety and Efficacy of Lenalidomide, VELCADE and dexamethasone in

Patients with Newly Diagnosed Multiple Myeloma: A Phase I/II Study

-- Lead investigator: Paul Richardson, M.D., Associate Professor of

Medicine, Harvard Medical School; Clinical Director, Jerome Lipper

Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston

-- Abstract #8520: Oral presentation session: Saturday, 31 May,

4:15 p.m. CT

Relapsed/Refractory Multiple Myeloma

Data will be presented from several studies of VELCADE based therapies for the treatment of relapsed MM. These data are expected to support the value of adding VELCADE in combination with emerging and established agents, including patients with renal insufficiency.

Non-Hodgkin's Lymphoma (NHL)

Beyond multiple myeloma, the Company continues to pursue and support trials in NHL, which is expected to be the next potential growth opportunity for VELCADE. Currently, VELCADE is the only approved therapy for patients with previously treated mantle cell lymphoma (MCL), the most aggressive form of NHL. ASCO-related data will be featured for VELCADE in combination with established agents in patients with relapsed MCL, indolent NHL and Waldenstrom's Macroglobulinemia, including:

-- Primary therapy of Waldenstrom's Macroglobulinemia with bortezomib,

dexamethasone and rituximab: results of WMCTG clinical trial 05-180

-- Lead investigator: Steven Treon, M.D., Ph.D., Assistant Professor in

Medicine, Harvard Medical School

-- Abstract #8519: Oral presentation session: Saturday, 31 May,

3:45 p.m. CT

In addition to these highlighted trials, the Company is expected to fully accrue patients by the first half of this year for a large, registration-enabling Phase III trial in follicular lymphoma. The trial is designed under a special protocol assessment (SPA) with

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
2. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
3. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
4. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
5. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
6. Data Presented at AAN Support Potential for Adjunctive use of Intravenous Lacosamide as Short-Term Replacement for Oral Treatment in Partial Epilepsy
7. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
8. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
9. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
10. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
11. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
Post Your Comments:
(Date:10/8/2015)... NEW BRUNSWICK, N.J. , Oct. 9, 2015 ... start of a safety and immunogenicity clinical trial in ... regimen in development at its Janssen Pharmaceutical Companies. Trial recruitment ... vaccine dose. This is the first study conducted of Janssen,s ... by the recent Ebola epidemic. Sierra Leone,s ...
(Date:10/8/2015)... Oct. 8, 2015  Trovagene, Inc., (NASDAQ:   ... announced the presentation of results from a field ... Cancer Monitoring SM (PCM) platform to accurately ... physicians to determine appropriate therapy for patients. ... Trovagene is delivering the results today in an ...
(Date:10/8/2015)... CAMBRIDGE, Mass. , Oct. 8, 2015 /PRNewswire/ ... has awarded approximately $40 million to the Broad ... whole genome sequencing of 20,000 individuals, as well ... sequencing and metabolite profiling. Trans-Omics for ... an initial step toward a larger initiative, which ...
Breaking Medicine Technology:
... - Phase 1b Combination Data Highlight Favorable Tolerability ... April 13, 2007 /PRNewswire-FirstCall/ -- ViroPharma,Incorporated today announced ... 796, a unique, orally dosed hepatitis C virus ... the European,Association for the Study of the Liver ...
... 2007 /PRNewswire/ -- Cequent,Pharmaceuticals, a pioneer in ... treatments to prevent and treat human disease,announced ... present a,scientific poster on Cequent's proprietary TransKingdom ... meeting of,the American Association of Cancer Research ...
Cached Medicine Technology:
(Date:10/9/2015)... ... 2015 , ... Prescription Hope, the fastest growing pharmacy program ... save money on the high cost of their prescription medications through their pharmacy ... families can receive their medications delivered direct from over 180 U.S.-based pharmaceutical manufacturers. ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... by Central Carolina Community Foundation (CCCF) in Columbia, South Carolina. In response, the ... needs of flood victims – both short and long term. 100% of monies ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... A variety of race options will be ... of Co-occurring Disorders on Sunday, October 18, at Al Lopez Park, 4810 North Himes Avenue, ... will include the choice of a 5K run or walk and a one-mile walk, followed ...
(Date:10/9/2015)... ... , ... When the producers of the popular ‘Ask This Old House’ PBS ... CA, they turned to a trusted resource in Tamarack Technologies. , “Our HV 1600 ... of our successful past experience with the show they enlisted our help,” said NelsonWarner, ...
(Date:10/9/2015)... ... ... In the heat of World War II and during the blitzkrieg on ... group of men were formed to disarm these bombs and protect the people and ... of unexploded bombs is of the highest importance. The work of the Bomb ...
Breaking Medicine News(10 mins):
... coordinator, explained how India’s legal stance on homosexuality is actually ... an// infringement of the human rights of homosexual men. ... to book, in cases dealing with sexual abuse of children. ... it may cause a setback to nailing those who commit ...
... their first month of life itself, the country stands a ... terms of// preventive measures each adopts to protect the young ... Report Card-2006, a report carried out by International Baby Food ... another 500,000 infants die in the country between the second ...
... 91, suffered a heart attack Sunday and was taken to ... medical bulletin described Pinochet's condition as "serious but stable". ... that his lungs were also affected. ,On Nov ... with a group of supporters gathering outside his home here ...
... through an innovative surgery has raised hope among the impotent.// ... the MGM Medical College in Indore, says the surgery - ... not only cure penile problems, but "also lead to an ... ,"Impotency may be the result of psychogenic, neurogenic or hormonal ...
... cells also has been found on the surface of a ... researchers isolate and purify// adult stem cells for use in ... researchers at UT Southwestern Medical Center report. ,The ... stem cells in bone marrow that give rise to fat, ...
... India is emerging as one of the most ... and manufacturing and clinical research as a result ... as Good Laboratory Practices, current Good Manufacturing Practices, ... ,As per the current provisions of the Income ...
Cached Medicine News:
Blood sedimentation rate analysis...
Blood sedimentation rate analysis...
... speed and precision in a flexible ... technology. With its advanced design, ... to 300 samples or 500 tests ... This high performance, fully automated analyzer ...
... lancing device that has set the standard ... This re-usable lancing device assists in obtaining ... is constructed in the USA of durable ... year after year. It's the only lancing ...
Medicine Products: